SEC Comment Letter 0000000000-23-013778 to MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: Dec. 18, 2023 · CIK: 0001680048 · Accession: 0000000000-23-013778
AI Filing Summary & Sentiment
File numbers found in text: 333-275997
Letter
United States securities and exchange commission logo December 18, 2023 Manuel Litchman, M.D. President and Chief Executive Officer Mustang Bio, Inc. 377 Plantation Street Worcester, Massachusetts 01605 Re:Mustang Bio, Inc. Registration Statement on Form S-1 Filed December 12, 2023 File No. 333-275997 Dear Manuel Litchman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rakesh Gopalan, Esq.
Show Raw Text
United States securities and exchange commission logo
December 18, 2023
Manuel Litchman, M.D.
President and Chief Executive Officer
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
Re:Mustang Bio, Inc.
Registration Statement on Form S-1
Filed December 12, 2023
File No. 333-275997
Dear Manuel Litchman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Rakesh Gopalan, Esq.